Press

PharmAla Biotech: CEO Letter to Shareholders

Sep 11 • 9 min read

From the desk of Nick Kadysh, Founding CEO, PharmAla Biotech “I just did my MDMA-assisted therapy yesterday. This modality is going to save so many lives. I am so in awe of your generosity to donate this magic medicine for my treatment. I feel that even after this first experience that I have solidified some…

Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023

Sep 8 • 2 min read

Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing cannabinoid pharmaceutical medicines and psychedelic therapies for unmet medical needs, is pleased to announce that it will be featured as a presenting company at the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023. Incannex will be presenting…

Colorado Seeks Public Views on Implementing Psychedelic Decriminalization

Sep 8 • 3 min read

Colorado officials will hold online hearings to gather public opinions on Colorado’s efforts to implement psychedelic decriminalization measures. The state became one of the first regions in the country to pass psychedelic policy after Colorado voters approved a measure to decriminalize several psychedelics for adults aged 21 years and older, setting the state on a path to legalize and…

Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction

Sep 7 • 4 min read

Lucy Scientific Discovery Inc. (“Lucy” or “the Company”) (NASDAQ: LSDI), a leading psychotropic innovator announces the acquisition of the intellectual property (IP) of High Times, the most recognizable and iconic brand in the cannabis industry. This acquisition provides a stream of high-margin licensing and royalty income from the well-regarded High Times, Cannabis Cup, and 420.com…

The Healing Company Appoints Biotech Visionaries Dr. Linda Friedland and Dr. Peter Kash as Advisors

Sep 7 • 5 min read

The Healing Company Inc. (OTCQB: HLCO) (“The Healing Company” or the “Company”) today announced the appointment of renowned biotech entrepreneurs and investors, Dr. Linda Friedland and Dr. Peter Kash, to the Company’s advisory board. Dr. Linda Friedland is an internationally recognized women’s health expert, sought-after speaker, and esteemed author of seven bestselling books. With a career spanning…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435